↓ Skip to main content

Clinical outcome, proteome kinetics and angiogenic factors in serum after thermoablation of colorectal liver metastases

Overview of attention for article published in BMC Cancer, May 2013
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clinical outcome, proteome kinetics and angiogenic factors in serum after thermoablation of colorectal liver metastases
Published in
BMC Cancer, May 2013
DOI 10.1186/1471-2407-13-266
Pubmed ID
Authors

Marieke WJLAE Wertenbroek, Marianne Schepers, Hannetta J Kamminga-Rasker, Jan T Bottema, Anneke C Muller Kobold, Han Roelofsen, Koert P de Jong

Abstract

Thermoablation is used to treat patients with unresectable colorectal liver metastases (CRLM). We analyze clinical outcome, proteome kinetics and angiogenic markers in patients treated by cryosurgical ablation (CSA) or radiofrequency ablation (RFA).

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 33%
Student > Bachelor 3 13%
Student > Master 3 13%
Student > Ph. D. Student 2 8%
Lecturer 1 4%
Other 1 4%
Unknown 6 25%
Readers by discipline Count As %
Medicine and Dentistry 14 58%
Nursing and Health Professions 3 13%
Biochemistry, Genetics and Molecular Biology 1 4%
Unknown 6 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 January 2015.
All research outputs
#17,738,777
of 22,780,165 outputs
Outputs from BMC Cancer
#4,959
of 8,288 outputs
Outputs of similar age
#139,623
of 195,211 outputs
Outputs of similar age from BMC Cancer
#77
of 97 outputs
Altmetric has tracked 22,780,165 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,288 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 195,211 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.